China's Probiotics E-Commerce Market in Q1 2024: A CN¥ 1.92B Market Navigating Contraction
By Quan Wenjun
5 min read
Executive Summary#
China's probiotics market on Taobao (淘宝) and Tmall (天猫) platforms posted CN¥ 1.92B in revenue during Q1 2024, down -13.8% YoY, as the confluence of market saturation, ingredient proliferation across product categories, and broader consumer caution applied downward pressure across all three major segments. Health supplements led revenue share at 41.0% but experienced the steepest decline at -27.0% YoY, while dairy products showed the greatest resilience at just -0.9%. The most compelling story, however, lies beneath the headline contraction: three emerging functional segments -- adjuvant therapy (+101.9%), oral health (+80.2%), and mood regulation (+64.1%) -- are rewriting the growth playbook through condition-specific positioning and social-commerce-native brand strategies.
A Market in Transition: -13.8% YoY but Structurally Evolving#
The Q1 2024 contraction is not a collapse but a transition. Over the preceding two years, probiotics gained broad consumer recognition for gut health and immune support benefits, driving a period of rapid expansion. That growth phase has now normalised as probiotics ingredients have spread across food, beverage, personal care, and supplement formats, fragmenting demand and intensifying price competition. Tmall (天猫) retained over 80% of platform revenue, reinforcing its role as the primary channel for branded probiotics, while Taobao's (淘宝) share fell to 18.0%.
The monthly sales data from April 2022 through March 2024 reveals a clear pattern: promotional events in June (618 Festival) and November (Double 11) generate pronounced peaks, with post-event months showing sharp retrenchment. The November 2023 peak of CN¥ 1.29B was followed by a December-February trough, confirming strong pull-forward effects. All three Q1 2024 months underperformed their Q1 2023 equivalents, indicating the decline is a sustained quarterly trend rather than a one-month anomaly.
Three Categories, Three Trajectories#
Health supplements command 41% of probiotics revenue despite steepest decline
Health Supplements: Where Established Segments Contract and New Ones Emerge#
Within the CN¥ 790M health supplements market, the eight functional segments tell a tale of two dynamics. Established segments are contracting: gut health (-35.5% YoY, 55.9% share), immune regulation (-7.7%, 10.6%), and women's intimate care (-23.6%, 6.8%) all declined as the initial post-pandemic probiotics awareness wave subsides.
Three emerging segments break through +50% YoY growth while traditional segments contract
Emerging Segment Highlights
-
Adjuvant therapy (+101.9% YoY, CN¥ 6.69M): Targeting IBS and inflammatory bowel conditions with imported specialist brands like Lifesflora (舒伯特), PrecisionBiotics (普葆), and Morinaga (森永). The CR10 of 84.5% and ASP of CN¥ 296 indicate a premium, concentrated market dominated by specialist international brands.
-
Oral health (+80.2% YoY, CN¥ 24.1M): The volume growth of +147.0% substantially outpaces revenue growth, indicating new consumer acquisition at lower price points. Earth Park (地球乐园) leads with CN¥ 6.15M (+257.8%), powered by sustained Douyin (抖音) KOL collaborations emphasising the "social embarrassment of bad breath."
-
Mood regulation (+64.1% YoY, CN¥ 5.5M): Targeting children, students, and adults with sleep difficulties, brands leverage anxiety-driven messaging around concentration and sleep quality, supporting premium positioning at CN¥ 341.7 ASP -- the second-highest across all segments.
What This Means for Brands#
The Q1 2024 probiotics data reveals a market that is simultaneously contracting at the macro level and expanding at the functional frontier. Brand teams should consider three strategic priorities:
-
Differentiate by condition, not ingredient. The growth gap between generic gut health probiotics (-35.5%) and condition-specific segments like adjuvant therapy (+101.9%) demonstrates that consumers are moving beyond generic "good for digestion" claims toward specific health outcomes.
-
Invest in social-commerce infrastructure. The oral health segment's explosive growth is fundamentally a social-commerce story, with Earth Park's +257.8% surge driven entirely by Douyin KOL partnerships. The content-to-commerce conversion loop is now the primary growth engine for emerging probiotics segments.
-
Watch dairy for volume signals. While health supplements contract, dairy probiotics are quietly gaining market share through habitual, everyday consumption. The +57% yoghurt growth and record March 2024 volumes suggest that consumers may be shifting their probiotics intake from premium supplement formats to more affordable dairy alternatives.
Key Takeaways#
- Taobao-Tmall probiotics market: CN¥ 1.92B, -13.8% YoY in Q1 2024
- Health supplements: CN¥ 790M (-27.0%), dairy: CN¥ 710M (-0.9%), other: CN¥ 420M (-2.3%)
- Gut health probiotics dominate at 55.9% share but fell -35.5% YoY
- Three emerging segments all surpassed +50% YoY growth: adjuvant therapy (+101.9%), oral health (+80.2%), mood regulation (+64.1%)
- Probiotic yoghurt surged approximately +57% YoY; March 2024 set the highest monthly dairy volume in two years
- Oral care probiotics within the "other" category grew +19.8%, reflecting oral microbiome mainstreaming
About the Data#
This analysis is based on Moojing Market Intelligence data covering Q1 2024 (January-March 2024), with comparative data from Q1 2023 and monthly trend data from April 2022 through March 2024. Platform coverage includes Taobao (淘宝) and Tmall (天猫)[1].
Download the Full Report
Download the full China Probiotics E-Commerce Q2 2024 report
This content adheres to Moojing's editorial standards .
Frequently Asked Questions
Because the ingredient succeeded. The market reached CN¥ 1.92 billion in Q1 2024, down -13.8% year on year, and the cause is not lost consumer interest but the spread of probiotics across food, beverage, personal care and supplement formats — which fragments demand and intensifies price competition. Health supplements led revenue share at 41.0% and CN¥ 790 million but fell furthest at -27.0%, while dairy proved most resilient at CN¥ 710 million and just -0.9%. The monthly pattern shows heavy promotional dependence: a November 2023 peak of CN¥ 1.29 billion followed by a December-to-February trough, and all three Q1 months coming in below their prior-year equivalents, so this is a sustained trend rather than a single soft month.
Three, all condition-specific, all above +50%. Adjuvant therapy grew +101.9% to CN¥ 6.69 million, targeting IBS and inflammatory bowel conditions through imported specialists — a premium, concentrated market with the ten largest brands at 84.5% and an average price of CN¥ 296. Oral health grew +80.2% to CN¥ 24.1 million, with volume up +147.0%, so it is acquiring new consumers at lower price points rather than upselling existing ones. Mood regulation grew +64.1% to CN¥ 5.5 million, aimed at children, students and adults with sleep difficulties, sustaining a CN¥ 341.7 average price on anxiety-framed messaging about concentration and sleep quality.
Whether the claim names a condition. Generic gut health still dominates the supplement category at 55.9% of it but moved -35.5%; immune regulation fell -7.7% and women's intimate care -23.6%. Meanwhile every segment tied to a specific health outcome grew above +50%. Consumers have moved past "good for digestion" toward a named problem they recognise in themselves, and the brands still selling the ingredient rather than the outcome are the ones absorbing the contraction. That is the single most actionable line in the dataset: differentiate by condition, not by ingredient.
In social-commerce infrastructure and in dairy volume signals. The oral health story is fundamentally a content-commerce one — its leading brand grew +257.8% to CN¥ 6.15 million on sustained creator collaborations built around the social embarrassment of bad breath, which is a scenario rather than a specification. The content-to-commerce loop is now the primary growth engine for emerging probiotics segments. Separately, watch dairy: probiotic yoghurt grew roughly +57% and March 2024 set the highest monthly dairy volume in two years, which suggests consumers may be shifting their probiotic intake from premium supplement formats into cheaper everyday dairy. If that is what is happening, the supplement contraction is partly a channel migration rather than a demand loss.
